Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Kurita D, Miura K, Nakagawa M, Ohtake S, Sakagami M, Uchino Y, Takahashi H, Kiso S, Hojo A, Kodaira H, Yagi M, Hirabayashi Y, Kobayashi Y, Iriyama N, Kobayashi S, Hatta Y, Kura Y, Sugitani M, Takei M. Kurita D, et al. Among authors: ohtake s. Int J Hematol. 2015 Jun;101(6):585-93. doi: 10.1007/s12185-015-1780-6. Epub 2015 Mar 17. Int J Hematol. 2015. PMID: 25776837
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Miura K, Takahashi H, Nakagawa M, Izu A, Sugitani M, Kurita D, Sakagami M, Ohtake S, Uchino Y, Hojo A, Kodaira H, Yagi M, Kobayashi Y, Iriyama N, Kobayashi S, Kiso S, Hirabayashi Y, Hatta Y, Takei M. Miura K, et al. Among authors: ohtake s. Leuk Lymphoma. 2016;57(6):1335-41. doi: 10.3109/10428194.2015.1096352. Epub 2015 Oct 22. Leuk Lymphoma. 2016. PMID: 26390147
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Miura K, Nakagawa M, Takahashi H, Uchino Y, Kodaira H, Iriyama N, Sakagami M, Ohtake S, Kobayashi S, Hojo A, Kurita D, Kobayashi Y, Kusuda M, Hirabayashi Y, Hatta Y, Takei M. Miura K, et al. Among authors: ohtake s. Int J Hematol. 2016 Mar;103(3):334-40. doi: 10.1007/s12185-015-1926-6. Epub 2015 Dec 29. Int J Hematol. 2016. PMID: 26715149 Clinical Trial.
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
Takahashi H, Miura K, Nakagawa M, Sugitani M, Amano Y, Kurita D, Sakagami M, Ohtake S, Uchino Y, Kodaira H, Iriyama N, Kobayashi S, Hojo A, Kobayashi Y, Hirabayashi Y, Kusuda M, Hatta Y, Nakayama T, Takei M. Takahashi H, et al. Among authors: ohtake s. Leuk Lymphoma. 2016 Dec;57(12):2784-2790. doi: 10.3109/10428194.2016.1167205. Epub 2016 Apr 13. Leuk Lymphoma. 2016. PMID: 27071312
Plasma cell maturity as a predictor of prognosis in multiple myeloma.
Iriyama N, Miura K, Hatta Y, Uchino Y, Kurita D, Takahashi H, Sakagami H, Sakagami M, Kobayashi Y, Nakagawa M, Ohtake S, Iizuka Y, Takei M. Iriyama N, et al. Among authors: ohtake s. Med Oncol. 2016 Aug;33(8):87. doi: 10.1007/s12032-016-0803-3. Epub 2016 Jul 6. Med Oncol. 2016. PMID: 27383407
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Kurita D, Takeuchi K, Kobayashi S, Hojo A, Uchino Y, Sakagami M, Ohtake S, Takahashi H, Miura K, Iriyama N, Sugitani M, Miyoshi H, Hatta Y, Ohshima K, Takei M. Kurita D, et al. Among authors: ohtake s. Virchows Arch. 2016 Oct;469(4):471-6. doi: 10.1007/s00428-016-1995-9. Epub 2016 Jul 25. Virchows Arch. 2016. PMID: 27457074
Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Miura K, Takahashi H, Nakagawa M, Hamada T, Uchino Y, Iizuka K, Ohtake S, Iriyama N, Hatta Y, Nakamura H. Miura K, et al. Among authors: ohtake s. Expert Rev Anticancer Ther. 2022 Jun;22(6):583-595. doi: 10.1080/14737140.2022.2071262. Epub 2022 May 5. Expert Rev Anticancer Ther. 2022. PMID: 35472312 Review.
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
Hamada T, Takahashi H, Nakagawa M, Nukariya H, Ito S, Endo T, Kurihara K, Koike T, Iizuka K, Ohtake S, Ichinohe T, Maebayashi T, Miura K, Hatta Y, Nakamura H. Hamada T, et al. Among authors: ohtake s. Case Rep Oncol. 2023 May 22;16(1):338-346. doi: 10.1159/000530265. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37384208 Free PMC article.
444 results